Ultomiris (ravulizumab)

pCPA File Number: 22307
Negotiation Status:
Concluded with an LOI
Indication(s):
Atypical hemolytic uremic syndrome
Sponsor/Manufacturer:
Alexion Pharma GmbH
CDA-AMC Project Number:
SR0740-000
pCPA Engagement Letter Issued:
Negotiation Process Concluded: